Secondary causes for thrombocytosis
Reading File
Searching for secondary causes of thrombocytosis now.
search_medical_text
secondary causes reactive thrombocytosis
Harrison's Principles of Internal Medicine, Twenty First Edition
Page 3450
GradeResponse
search_medical_text
reactive thrombocytosis etiology infection malignancy surgery splenectomy
Harrison's Principles of Internal Medicine, Twenty First Edition
Page 3450
GradeResponse
Based on Harrison's (p. 3450) and supplemented with established clinical knowledge, here is a comprehensive overview:
Secondary (Reactive) Thrombocytosis
Secondary thrombocytosis results from an underlying condition that stimulates platelet production — primarily via elevated thrombopoietin (TPO), IL-6, or IL-11 — without intrinsic clonal marrow disease. Platelet function is typically normal, and thrombotic risk is generally not significantly increased.
Major Categories and Causes
| Category | Examples |
|---|---|
| Iron deficiency anemia | Most common single cause; mechanism unclear but well-established |
| Infection | Bacterial (pneumonia, TB, osteomyelitis), fungal, viral |
| Inflammatory / Autoimmune | Rheumatoid arthritis, IBD, SLE, vasculitis, sarcoidosis |
| Tissue injury / Surgery | Post-operative state, trauma, burns |
| Malignancy | Solid tumors (lung, GI, ovarian), lymphoma (paraneoplastic) |
| Splenectomy / Asplenia | Loss of platelet sequestration + splenic TPO clearance; counts can rise dramatically |
| Hemolytic anemia | Chronic hemolysis drives compensatory marrow activity |
| Rebound thrombocytosis | After thrombocytopenia recovery (e.g., post-chemotherapy, alcohol cessation) |
| Medications | Vincristine, epinephrine, corticosteroids, thrombopoietic growth factors (e.g., eltrombopag) |
| Exercise | Transient, due to splenic contraction |
| Functional hyposplenism | Celiac disease, sickle cell disease |
Key Points
- Iron deficiency should always be ruled out first — it is the most common and easily correctable cause (Harrison's p. 3450).
- Splenectomy can cause the most dramatic reactive thrombocytosis (platelet counts often >1,000 × 10⁹/L), but thrombotic risk is primarily from loss of splenic filtering, not the high count itself.
- Reactive vs. clonal: In reactive thrombocytosis, CRP/ESR are often elevated, platelet morphology is normal, and JAK2/CALR/MPL mutations are absent — features that help distinguish it from essential thrombocythemia.
- Platelet counts >1.5 million (rare in reactive states, more common in myeloproliferative disorders) paradoxically increase bleeding risk via acquired von Willebrand disease (Harrison's p. 3450).
Diagnostic Approach
- Full history and exam (infection, inflammation, prior surgery/splenectomy)
- CBC with differential + peripheral smear
- Iron studies, ferritin
- Inflammatory markers (CRP, ESR)
- Exclude malignancy if clinically indicated
- If reactive cause not identified → consider JAK2 V617F, CALR, MPL mutations to evaluate for clonal disease
This is a shared conversation. Sign in to Orris to start your own chat.